Found 5 matching trials
BE Study of the Combinations of Gemigliptin 50mg and Metformin HCl Extended Release 1000mg in Comparison to Each Component Administered Alone PHASE1 This study is to evaluate the safety/tolerability and pharmacokinetics/phar...
Show More Location
Seoul National University Hospital
Learn More & Join Trial
BE Study of the Combinations of Gemigliptin/Metformin HCl Extended Release 50/1000mg(25/500mg x 2 Tablets) in Comparison to Each Component Administered Alone PHASE1 This study is to compare the safety/tolerability and pharmacokinetics/pharm...
Show More Location
Seoul National University Hospital
Learn More & Join Trial
BE Study of the Combinations of Gemigliptin 50mg and Metformin HCl Extended Release 500mg in Comparison to Each Component Administered Alone PHASE1 This study is to evaluate the safety/tolerability and pharmacokinetics of t...
Show More Location
Seoul National University Hospital
Learn More & Join Trial
BE Study of the Combinations of Gemigliptin 50mg and Metformin HCl Extended Release 1000mg in Comparison to Each Component Administered Alone. PHASE1 This study is to evaluate the safety/tolerability and pharmacokinetics of t...
Show More Location
Asan Medical Center
Learn More & Join Trial
BE Study of the Combinations of Gemigliptin 50mg and Metformin HCl Extended Release 2000mg in Comparison to Each Component Administered Alone PHASE1 A Randomized, Open-label, Single-dose, Two-way Crossover Clinical Trial to ...
Show More Location
Yonsei University College of Medicine
Learn More & Join Trial